These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 8234698

  • 21. [Computed tomography of thymic hyperplasia in older children].
    Nakata H, Watanabe H, Imada H, Nobe T, Tasaka H.
    Rinsho Hoshasen; 1989 Jul; 34(7):805-10. PubMed ID: 2795928
    [Abstract] [Full Text] [Related]

  • 22. Hodgkin disease: CT of the thymus.
    Heron CW, Husband JE, Williams MP.
    Radiology; 1988 Jun; 167(3):647-51. PubMed ID: 3363120
    [Abstract] [Full Text] [Related]

  • 23. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
    Brisse H, Pacquement H, Burdairon E, Plancher C, Neuenschwander S.
    Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
    [Abstract] [Full Text] [Related]

  • 24. High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma.
    Peylan-Ramu N, Haddy TB, Jones E, Horvath K, Adde MA, Magrath IT.
    J Clin Oncol; 1989 Dec; 7(12):1800-6. PubMed ID: 2585021
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
    Nikpoor N, Aliabadi P, Diaz L, Mannting F.
    Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
    [Abstract] [Full Text] [Related]

  • 26. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
    Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Moellers M, Buerke B, Stoevesandt D.
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30421. PubMed ID: 37243889
    [Abstract] [Full Text] [Related]

  • 27. The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease.
    Heron CW, Husband JE, Williams MP, Cherryman GR.
    Br J Radiol; 1988 Jul; 61(727):567-72. PubMed ID: 3408843
    [Abstract] [Full Text] [Related]

  • 28. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
    Canini R, Battista G, Monetti N, Pisi P, Fanti S, Zinzani PL, Zompatori M, Bendandi M, Gherlinzoni F, Corinaldesi A.
    Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
    [Abstract] [Full Text] [Related]

  • 29. Follow-up of mediastinal lymphoma: role of ultrasonography.
    De Pascale A, Giorcelli R, Garofalo G, Perotto F, Parvis G, Gino M, Fava C.
    Radiol Med; 2006 Sep; 111(6):759-72. PubMed ID: 16896564
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
    Rahmouni A, Divine M, Lepage E, Jazaerli N, Belhadj K, Gaulard P, Golli M, Reyes F, Vasile N.
    Radiology; 2001 Jun; 219(3):621-8. PubMed ID: 11376245
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M, Paucek B, Raida L, Myslivecek M, Zapletalová J.
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [Abstract] [Full Text] [Related]

  • 37. Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge.
    Feldges A, Wagner HP, Bubeck B, Kehrer B, Ries G, Schmid U, Waibel P.
    Pediatr Surg Int; 1997 Dec; 12(8):613-7. PubMed ID: 9354739
    [Abstract] [Full Text] [Related]

  • 38. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging.
    Nyman R, Forsgren G, Glimelius B.
    Acta Radiol; 1996 May; 37(3 Pt 1):323-6. PubMed ID: 8845262
    [Abstract] [Full Text] [Related]

  • 39. Residual masses on follow-up computed tomography in patients with mediastinal non-Hodgkin's lymphoma.
    Uematsu M, Kondo M, Tsutsui T, Murase T, Yorozu A, Hiramatsu H, Fujii H, Hashimoto S.
    Clin Radiol; 1989 May; 40(3):244-7. PubMed ID: 2752680
    [Abstract] [Full Text] [Related]

  • 40. Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection.
    Qiu L, Zhao Y, Yang Y, Huang H, Cai Z, He J.
    BMC Surg; 2021 Jan 14; 21(1):38. PubMed ID: 33446156
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.